Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008
INVESTING IN MID-CAP & SMALL CAP GROWTH STOCKS - DAVID P. NOLAN - BB&T ASSET MANAGEMENT, INC.
June 23, 2008
INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008
Dr. John A. Scarlett - Tercica, Inc. (trca)
July 12, 2007
Edward Lanphier - Sangamo Biosciences Inc (sgmo)
February 27, 2006
J.brown / F.theeuwes - Durect Corporation (drrx)
October 26, 2004
William Dow - Aksys Ltd (aksy)
May 03, 2004
Jack Bowman - Neorx Corporation (nerx)
October 17, 2003
Roundtable Forum: Gaming
October 06, 2003
Investment Opportunities In The Energy Supply Chain: J.smith - Gabelli Asset Management
September 01, 2003
Therapeutics-based Companies: Mark Schoenebaum - U.s. Bancorp Piper Jaffray Inc
July 28, 2003
Ian Smith - Vertex Pharmaceuticals Inc (vrtz)
June 02, 2003
Peter Ganucheau Iv - Gsb Investment Management Inc
April 28, 2003
Funding Private Healthcare: Carl Gordon - Orbimed Advisors Inc
October 14, 2002
Mark Davidson - Fiduciary Services Corporation
July 08, 2002
Fixed Wireless Equipment: Colin Mcardle - Bear, Stearns & Co
June 12, 2002
Michael Hart - Allos Therapeutics Inc (alth)
June 02, 2002
